HbA1c Normal but Blood Sugar High: What the Mismatch Means

Yes, you can have a normal HbA1c and genuinely high blood glucose, and it is common enough that it should not be your first surprise. HbA1c estimates the average glucose your red blood cells were exposed to over roughly the preceding two to three months, weighted toward the most recent weeks. A fingerstick or a continuous glucose monitor (CGM) reading is an instantaneous measurement. A person who sits at 85 mg/dL overnight and fasting, then hits 190 mg/dL for ninety minutes after a bowl of rice, can carry a 24-hour mean glucose near 105 mg/dL and an HbA1c of 5.4%. Both numbers are correct. They answer different questions. The interesting cases are the ones where the mismatch is larger than postprandial arithmetic can explain, and those usually come down to red blood cell biology or assay interference.

The two numbers measure different quantities

HbA1c is the fraction of hemoglobin A that has been non-enzymatically glycated at the N-terminal valine of the beta chain. Glycation is slow, essentially irreversible, and proportional to both glucose concentration and the time the red cell spends in circulation. That means HbA1c is a product of glucose exposure and red cell lifespan. Glucose alone does not set it ¹. A CGM measures interstitial glucose every five minutes and tells you about excursions, variability, and timing. None of that survives the averaging that HbA1c performs.

The standard translation between them comes from the A1c-Derived Average Glucose study: estimated average glucose in mg/dL equals 28.7 × A1c − 46.7. So 5.4% maps to about 108 mg/dL and 5.9% to about 122 mg/dL. Running the same relationship in the other direction from CGM data gives the glucose management indicator: GMI (%) = 3.31 + 0.02392 × mean glucose in mg/dL. Comparing your measured HbA1c against your CGM-derived GMI over the same window is the single most useful diagnostic step available to you, and it costs nothing if you already have both.

Start by checking the arithmetic

Before reaching for exotic explanations, confirm that the mismatch exists. Two failure modes account for most apparent discrepancies. The first is a window mismatch: a lab A1c drawn today reflects glucose from the past eight to twelve weeks, so comparing it to a single week of CGM data after a diet change is comparing different time periods. Use at least 14 days of CGM data, and preferably 28, aligned to the weeks before the blood draw.

The second is scale confusion. A fasting reading of 108 mg/dL feels high if you expected 85, but it corresponds to an A1c well inside the normal range. Postprandial peaks of 160 to 180 mg/dL in people without diabetes are ordinary and contribute only a few points of average, because they last under two hours.

If the gap survives both checks, quantify it. A CGM mean of 140 mg/dL predicts a GMI near 6.66%. If your lab A1c comes back at 5.5%, that is a 1.1-point discrepancy. It falls far outside assay imprecision, and the explanation is almost certainly biological.

Red cell turnover is the usual biological explanation

Anything that shortens red cell survival lowers HbA1c independent of glucose, because cells are cleared before they accumulate their full glycation load. The following all pull HbA1c down relative to true mean glucose ².

• hemolysis
• recent blood loss
• iron or B12 repletion in progress
• chronic kidney disease with erythropoietin therapy
• hypersplenism
• cirrhosis

Conversely, iron deficiency anemia and asplenia lengthen mean red cell age and push HbA1c up. Red cell indices from an ordinary complete blood count carry more information about this than most people expect, and their association with glycemic measures has been studied directly ³⁴.

The parameters to look at are mean corpuscular volume, red cell distribution width, and reticulocyte count or percentage. Also check haptoglobin and ferritin with transferrin saturation. A reticulocyte percentage above roughly 2.5% with a low haptoglobin points toward accelerated turnover. High RDW with low ferritin points the other way. None of this is self-interpretation territory once values fall outside reference ranges, and a clinician should read the panel.

There is also a stable, person-specific component that has nothing to do with disease. Individuals differ in how much HbA1c they generate per unit of glucose exposure, a reproducible offset often called the glycation gap or hemoglobin glycation index. It is consistent within a person over time and appears to track with differences in intracellular glucose handling and red cell physiology ⁵. Someone with a persistently low glycation index will run an A1c several tenths of a point below what their glucose data predicts, every single time, with no pathology involved.

Assay interference and hemoglobin variants

The third category is analytical. Hemoglobin variants such as HbS, HbC, HbE, and HbD trait alter the measurement depending on method. Cation-exchange HPLC separates by charge and can co-elute or mis-integrate variant peaks. Immunoassays depend on antibody recognition of the glycated N-terminal epitope and can be affected if the variant changes the surrounding sequence. Boronate affinity chromatography binds cis-diol groups on the glycated residue and is the most tolerant of variants, which is why it is the method to request if a variant is suspected. Elevated HbF above about 10 to 15% depresses results on most platforms. Carbamylated hemoglobin in advanced uremia and acetylated hemoglobin from very high-dose salicylate can read as interference on some HPLC systems. The limits of HbA1c as a standalone marker of control are well documented ⁶, and the assay’s diagnostic performance depends on knowing which method produced the number ⁷.

Ask your lab which method it uses and whether the result was flagged for an abnormal chromatogram. That information exists in the lab’s LIS and is rarely printed on the patient-facing report.

What to measure when HbA1c is untrustworthy

When red cell biology makes HbA1c unreliable, the alternatives are glycated proteins with shorter half-lives. Fructosamine reflects total serum protein glycation over about two to three weeks. Glycated albumin, expressed as a percentage of total albumin, covers a similar window with better specificity and is less distorted by total protein concentration. It is still skewed by nephrotic syndrome, protein-losing states, and thyroid disease ¹⁸. Neither is affected by red cell lifespan, which is exactly the point.

A CGM worn for two weeks remains the highest-resolution option. Beyond mean glucose, compute time in range 70 to 180 mg/dL and the percentage of readings above 140 and above 180. Then compute the coefficient of variation, where a CV above 36% indicates high variability, along with the distribution of post-meal peaks. A 75 g oral glucose tolerance test with glucose and insulin at 0, 30, 60, and 120 minutes remains the reference method for characterizing post-load handling, and ordering and interpreting it is a clinician’s job.

Working with your own CGM export

Dexcom exports CSV with a Timestamp (YYYY-MM-DDThh:mm:ss) column and Glucose Value (mg/dL), using the strings Low and High for readings outside 40 to 400. Libre exports a Device Timestamp in local time with historic and scan glucose in separate columns. Filter to historic readings only before averaging, because scan values oversample the moments you chose to check.

import pandas as pd

df = pd.read_csv("dexcom.csv", parse_dates=["Timestamp (YYYY-MM-DDThh:mm:ss)"])
g = pd.to_numeric(df["Glucose Value (mg/dL)"], errors="coerce").dropna()

mean = g.mean()
print(f"mean {mean:.1f} mg/dL")
print(f"GMI  {3.31 + 0.02392 * mean:.2f} %")
print(f"CV   {100 * g.std() / mean:.1f} %")
print(f"TIR  {100 * g.between(70, 180).mean():.1f} %")
print(f">140 {100 * (g > 140).mean():.1f} %")

Require at least 70% sensor coverage over the window before trusting these numbers, and drop the first 12 hours after each sensor insertion, where readings tend to run low.

Questions people also ask

Is it normal to have high blood glucose even with a normal A1C? Yes. Short postprandial spikes contribute little to a two-to-three-month average, so a person can peak at 170 to 190 mg/dL after meals and still return an A1c of 5.4%.

Can you be diabetic but have a normal A1C? It happens. HbA1c alone misses a meaningful fraction of cases identified by oral glucose tolerance testing, and conditions that shorten red cell survival lower the result further ⁶. Diagnosis requires a clinician using more than one measurement.

What is more important, fasting glucose or HbA1c? Neither dominates. Fasting glucose captures hepatic glucose output overnight, HbA1c captures long-run exposure, and A1c in the 5.7 to 6.4% range carries substantially elevated risk of progression to diabetes over five years ⁹. Together with post-meal data they describe different parts of the same system.

Can your blood sugar be normal but A1C high? Yes. Iron deficiency, asplenia, and a high personal glycation index are common reasons. Confirm with fructosamine or glycated albumin, which do not depend on red cell lifespan ¹.

How do I bring my blood sugar down immediately? We do not give treatment guidance. Acute glucose management is a medical decision, and a reading that worries you belongs in front of a clinician the same day.

Footnotes

1. Maja Krhač, Marijana Vučić Lovrenčić. Update on biomarkers of glycemic control. World Journal of Diabetes, 2019. https://doi.org/10.4239/wjd.v10.i1.1 ↩ ↩² ↩³

2. Mathew Clarke, Jamila Benmoussa, Amulya Penmetsa, et al. Inaccuracies of Hemoglobin A1c in Liver Cirrhosis: A Case Report. Journal of Endocrinology and Metabolism, 2016. https://doi.org/10.14740/jem326w ↩

3. Priyadarsini Dhavakumar, Latha Ramalingam, Vanathy Karunamoorthy. Red Blood Cell Parameters as Cost-effective Biomarkers in Normal and Altered Glycemic States: A Cross-sectional Study. International Journal of Applied & Basic Medical Research, 2026. https://doi.org/10.4103/ijabmr.ijabmr_112_26 ↩

4. Abdullah AlJedai, Hajar Amin, Fuad Alanazi, et al. The Association Between HbA1c Levels And Hematological Biomarkers in Adults with Type 2 Diabetes Mellitus: A Retrospective Study. International Journal of General Medicine, 2025. https://doi.org/10.2147/ijgm.s572310 ↩

5. R. David G. Leslie, Robert M. Cohen. Biologic Variability in Plasma Glucose, Hemoglobin A1c, and Advanced Glycation End Products Associated with Diabetes Complications. Journal of Diabetes Science and Technology, 2009. https://doi.org/10.1177/193229680900300403 ↩

6. Georgia Kaiafa, Stavroula Veneti, George Polychronopoulos, et al. Is HbA1c an ideal biomarker of well-controlled diabetes?. Postgraduate Medical Journal, 2020. https://doi.org/10.1136/postgradmedj-2020-138756 ↩ ↩²

7. Shariq I. Sherwani, Haseeb A. Khan, Aishah Ekhzaimy, et al. Significance of HbA1c Test in Diagnosis and Prognosis of Diabetic Patients. Biomarker Insights, 2016. https://doi.org/10.4137/bmi.s38440 ↩

8. Timothy J. Lyons, Arpita Basu. Biomarkers in diabetes: hemoglobin A1c, vascular and tissue markers. Translational Research, 2012. https://doi.org/10.1016/j.trsl.2012.01.009 ↩

9. Xuanping Zhang, Edward W. Gregg, David F. Williamson, et al. A1C Level and Future Risk of Diabetes: A Systematic Review. Diabetes Care, 2010. https://doi.org/10.2337/dc09-1939 ↩